KR20010080970A - 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도 - Google Patents
에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도 Download PDFInfo
- Publication number
- KR20010080970A KR20010080970A KR1020017005854A KR20017005854A KR20010080970A KR 20010080970 A KR20010080970 A KR 20010080970A KR 1020017005854 A KR1020017005854 A KR 1020017005854A KR 20017005854 A KR20017005854 A KR 20017005854A KR 20010080970 A KR20010080970 A KR 20010080970A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- methyl
- compounds
- compound
- dideoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
실시예 1 | 실시예 2 | |
스트렙토코커스 파이오젠스 | 2.5 | 0.3 |
스트렙토코커스 뉴모니아 | 1.2 | 0.150 |
Claims (9)
- 신규 화학 생성물로서의 화학식 (Ⅰ)의 화합물 또는 그의 산 부가염.<화학식 Ⅰ>상기 식에서, X는 수소 원자 또는 할로겐 원자이고, Z는 수소 원자 또는 산의 반응 잔기이다.
- 제1항에 있어서, X가 불소 원자인 화학식 (Ⅰ)의 화합물.
- 제1항 또는 제2항에 있어서, Z가 수소 원자인 화학식 (Ⅰ)의 화합물.
- 제1항에 있어서, 신규 화학 생성물로서의 11,12-디데옥시-3-데[(2,6-디데옥시-3-C-메틸-3-O-메틸-알파-L-리보헥소피라노실)옥시]-6-O-메틸-3-옥소-12,11-[옥시카르보닐[[4-[4-(4-아미노페닐)-1H-아미다졸-1-일]부틸]이미노]]-에리쓰로마이신.
- 제1항에 있어서, 신규 화학 생성물로서의 2-플루오로-11,12-디데옥시-3-데[(2,6-디데옥시-3-C-메틸-3-O-메틸-알파-L-리보헥소피라노실)옥시]-6-O-메틸-3-옥소-12,11-[옥시카르보닐[[4-[4-(4-아미노페닐)-1H-아미다졸-1-일]부틸]이미노]]-에리쓰로마이신.
- 화학식 (Ⅱ)의 화합물에 화학식 (Ⅲ)의 화합물을 작용시켜 상응하는 화학식 (Ⅰa)의 화합물을 생성하고, 이어서 필요한 경우에는 화학식 (Ⅰa)의 화합물에 2' 위치에서 히드록실 관능을 나타내는 화합물을 작용시키고(거나) 산을 작용시켜 염을 형성하는 것을 특징으로 하는, 제1항 내지 제5항 중 어느 한 항에 정의된 화학식 (Ⅰ) 화합물의 제조 방법.<화학식 Ⅱ>(식 중, X는 상기 정의한 바와 같고, OM은 아실 라디칼의 반응 잔기임)<화학식 Ⅲ>
- 신규 화합물로서, 제6항에 정의된 화학식 (Ⅲ)의 화합물.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 의약으로서 사용되는 화학식 (Ⅰ)의 화합물 또는 약제학상 허용되는 그의 산 부가염.
- 제8항에 따른 1종 이상의 화합물을 활성 성분으로서 함유하는 제약 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9814145A FR2785612A1 (fr) | 1998-11-10 | 1998-11-10 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR98/14145 | 1998-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010080970A true KR20010080970A (ko) | 2001-08-25 |
KR100567695B1 KR100567695B1 (ko) | 2006-04-05 |
Family
ID=9532584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017005854A KR100567695B1 (ko) | 1998-11-10 | 1999-11-09 | 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도 |
Country Status (28)
Country | Link |
---|---|
US (2) | US6455505B2 (ko) |
EP (1) | EP1016669B1 (ko) |
JP (1) | JP4698783B2 (ko) |
KR (1) | KR100567695B1 (ko) |
CN (2) | CN1240708C (ko) |
AR (1) | AR025814A1 (ko) |
AT (1) | ATE232879T1 (ko) |
AU (1) | AU766138B2 (ko) |
BR (1) | BR9915236A (ko) |
CA (1) | CA2350651C (ko) |
CZ (1) | CZ20011622A3 (ko) |
DE (1) | DE69905447T2 (ko) |
DK (1) | DK1016669T3 (ko) |
EA (1) | EA200100533A1 (ko) |
ES (1) | ES2189365T3 (ko) |
FR (1) | FR2785612A1 (ko) |
HR (1) | HRP20010335B1 (ko) |
HU (1) | HUP0104035A3 (ko) |
IL (2) | IL142996A0 (ko) |
NO (1) | NO20012272L (ko) |
NZ (1) | NZ511609A (ko) |
PL (1) | PL348098A1 (ko) |
PT (1) | PT1016669E (ko) |
SI (1) | SI20640A (ko) |
TR (1) | TR200101286T2 (ko) |
TW (1) | TWI237027B (ko) |
WO (1) | WO2000027857A2 (ko) |
ZA (1) | ZA200103801B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0105190A3 (en) | 1999-01-27 | 2003-03-28 | Pfizer Prod Inc | Ketolide antibiotics, medicaments containing them and their use |
JP2003500414A (ja) | 1999-05-24 | 2003-01-07 | ファイザー・プロダクツ・インク | 13−メチルエリスロマイシン誘導体 |
EP1167376B1 (en) | 2000-06-30 | 2004-07-14 | Pfizer Products Inc. | Macrolide antibiotics |
JP2004017020A (ja) * | 2002-06-20 | 2004-01-22 | Sony Corp | コーティング方法および被コーティング粒子 |
US7601695B2 (en) * | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
BRPI0513903A (pt) * | 2004-07-28 | 2008-05-20 | Ranbaxy Lab Ltd | derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos |
WO2006046112A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
WO2009055557A1 (en) | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
US8796232B2 (en) | 2008-10-24 | 2014-08-05 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ,インコーポレイテッド | マラリア、結核、及びmac病の治療方法 |
WO2011119604A1 (en) | 2010-03-22 | 2011-09-29 | Cempra Pharmaceuticals, Inc. | Crystalline forms of a macrolide, and uses therefor |
BR112012029586A2 (pt) | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos |
KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
CA2868262A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
CN105163785A (zh) | 2013-03-14 | 2015-12-16 | 森普拉制药公司 | 用于治疗呼吸道疾病的方法及其制剂 |
CA2907085A1 (en) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
KR102363621B1 (ko) | 2013-04-04 | 2022-02-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 매크롤라이드 그리고 그의 제조방법 및 용도 |
WO2016057798A1 (en) | 2014-10-08 | 2016-04-14 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
US10640528B2 (en) | 2015-03-25 | 2020-05-05 | President And Fellows Of Havard College | Macrolides with modified desosamine sugars and uses thereof |
EP3190122A1 (en) * | 2016-01-08 | 2017-07-12 | LEK Pharmaceuticals d.d. | A novel synthetic pathway towards solithromycin and purification thereof |
CN106432383A (zh) * | 2016-09-14 | 2017-02-22 | 重庆两江药物研发中心有限公司 | 索利霉素及其中间体的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
FR2669337B1 (fr) * | 1990-11-21 | 1995-03-24 | Roussel Uclaf | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
WO1998009978A1 (en) * | 1996-09-04 | 1998-03-12 | Abbott Laboratories | 6-o-substituted ketolides having antibacterial activity |
AU4472897A (en) * | 1997-03-10 | 1998-09-29 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
-
1998
- 1998-11-10 FR FR9814145A patent/FR2785612A1/fr active Pending
-
1999
- 1999-11-03 US US09/433,146 patent/US6455505B2/en not_active Expired - Lifetime
- 1999-11-08 TW TW088119491A patent/TWI237027B/zh not_active IP Right Cessation
- 1999-11-09 PL PL99348098A patent/PL348098A1/xx not_active Application Discontinuation
- 1999-11-09 PT PT99402783T patent/PT1016669E/pt unknown
- 1999-11-09 CN CNB998154393A patent/CN1240708C/zh not_active Expired - Lifetime
- 1999-11-09 WO PCT/FR1999/002718 patent/WO2000027857A2/fr active IP Right Grant
- 1999-11-09 CZ CZ20011622A patent/CZ20011622A3/cs unknown
- 1999-11-09 EP EP99402783A patent/EP1016669B1/fr not_active Expired - Lifetime
- 1999-11-09 BR BR9915236-3A patent/BR9915236A/pt active Search and Examination
- 1999-11-09 IL IL14299699A patent/IL142996A0/xx active IP Right Grant
- 1999-11-09 CA CA2350651A patent/CA2350651C/fr not_active Expired - Lifetime
- 1999-11-09 ES ES99402783T patent/ES2189365T3/es not_active Expired - Lifetime
- 1999-11-09 DE DE69905447T patent/DE69905447T2/de not_active Expired - Lifetime
- 1999-11-09 CN CNB200510128838XA patent/CN100351238C/zh not_active Expired - Lifetime
- 1999-11-09 DK DK99402783T patent/DK1016669T3/da active
- 1999-11-09 NZ NZ511609A patent/NZ511609A/en unknown
- 1999-11-09 SI SI9920091A patent/SI20640A/sl not_active IP Right Cessation
- 1999-11-09 TR TR2001/01286T patent/TR200101286T2/xx unknown
- 1999-11-09 JP JP31801599A patent/JP4698783B2/ja not_active Expired - Lifetime
- 1999-11-09 KR KR1020017005854A patent/KR100567695B1/ko active IP Right Grant
- 1999-11-09 HU HU0104035A patent/HUP0104035A3/hu unknown
- 1999-11-09 AT AT99402783T patent/ATE232879T1/de active
- 1999-11-09 AU AU10526/00A patent/AU766138B2/en not_active Expired
- 1999-11-09 EA EA200100533A patent/EA200100533A1/ru unknown
- 1999-11-10 AR ARP990105702A patent/AR025814A1/es not_active Application Discontinuation
-
2000
- 2000-12-11 US US09/734,162 patent/US6407257B1/en not_active Expired - Lifetime
-
2001
- 2001-05-06 IL IL142996A patent/IL142996A/en not_active IP Right Cessation
- 2001-05-09 NO NO20012272A patent/NO20012272L/no not_active Application Discontinuation
- 2001-05-10 HR HR990077A patent/HRP20010335B1/xx not_active IP Right Cessation
- 2001-05-10 ZA ZA200103801A patent/ZA200103801B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100567695B1 (ko) | 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도 | |
JP2992540B2 (ja) | 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用 | |
KR100319358B1 (ko) | 신규에리트로마이신 유도체, 그의 제조방법 및 의약으로서의 그의 용도 | |
KR100317148B1 (ko) | 신규한에리트로마이신유도체,그의제조방법및약제로서의그의용도 | |
KR100486053B1 (ko) | 신규에리트로마이신유도체,그의제조방법및약제로서의그의용도 | |
KR100371473B1 (ko) | 신규한에리스로마이신유도체,그의제조방법및의약으로서의용도 | |
KR100587445B1 (ko) | 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도 | |
US6313101B1 (en) | Derivatives of erythromycin, their preparation process and their use as medicaments | |
KR100458240B1 (ko) | 신규 에리트로마이신 유도체, 그의 제조방법 및 의약으로서의용도 | |
KR100490074B1 (ko) | 신규한 에리트로마이신 유도체, 그의 제조 방법 및 의약품으로서의 그의 용도 | |
FR2754821A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
KR20000062286A (ko) | 신규한 에리트로마이신 유도체, 제조 방법 및 의약품으로서 용도 | |
JP2001518475A (ja) | 環状亜リン酸およびリン酸塩 | |
JP4583601B2 (ja) | 新規の6−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130305 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150302 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160303 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170302 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 14 |